Status:
COMPLETED
Clonidine Versus Adenosine to Treat Neuropathic Pain
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Pain
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effects of clonidine and adenosine on nerve pain.
Detailed Description
This study is part of a pain center grant that focuses on how pain, especially chronic neuropathic pain, alters the response to traditional and non-traditional analgesics (pain medications). Clonidin...
Eligibility Criteria
Inclusion
- Patients with complex regional pain syndrome (CRPS), type I involving a lower extremity
Exclusion
- Pregnancy
- Allergy to clonidine
- Currently taking clonidine or other direct a2-adrenergic agonists, or taking cholinesterase inhibitors
- Patients with any serious or unstable medical problems (heart, lung, liver, kidney, or nervous system disease)
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00349921
Start Date
August 1 2004
End Date
January 1 2008
Last Update
September 10 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Center for Clinical Research, 145 Kimel Park Drive
Winston-Salem, North Carolina, United States, 27103
2
Wake Forest University School of Medicine, Medical Center Boulevard
Winston-Salem, North Carolina, United States, 27157-1009